http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03215421-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 1990-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c770f8fe49600c6a4da6a0e813be59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0553591b849b8a87c650bcfc4ff5e97d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_626c8bec4e7bf1aa0a84e3b516df40b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73a53703b5cdb6582ae13ea7614f2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aeb7b82e723e343f3d7e76dac12902d |
publicationDate | 1991-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H03215421-A |
titleOfInvention | Disease treating agent containing aromatic derivative as active ingredient |
abstract | PURPOSE: To obtain a treating agent for disease being in onset thereof by stimulation of exogenous coagulation reaction, containing an aromatic derivative as an active ingredient and having isolation suppressing action on tissue thromboplastin. n CONSTITUTION: An aromatic derivative expressed by the formula (R 1 is H or methyl) is added as an active ingredient and properly blended with a carrier for preparation, vehicle, additive, etc., ordinarily employed. The blending is according to ordinary method in providing the objective agent. The agent can be prepared in a form of a solid preparation such as tablet, pill, inhalant or granule, liquid preparation such as emulsion, solution, suspension or syrup and external preparation such as ointment, gel ointment, cream or cataplasm. The agent is useful for treatment and prevention of shock, disorders in respiratory, renal, and hepatic functions, peripheral necrosis, consciousness disorders, etc., which show the symptoms by releasing tissue thromboplastin into blood due to the disorders by malignant tumor, injury, operation, fulminant hepatitis, acute leukemia, etc., being causative of accelerating blood coagulation. n COPYRIGHT: (C)1991,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5945450-A |
priorityDate | 1990-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280686 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13726 |
Total number of triples: 22.